ArticleApplied microbiology and biotechnology2026
Characterization of a novel bifunctional endo-β-1,4-glucanase/mannanase from Aspergillus oryzae.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The present study involved a global search of the Aspergillus oryzae genome database. As a result, the gene (gene ID: AO090011000715) encoding a putative endo-β-1,4-glucanase of the glycoside hydrolase family 5 possessing a carbohydrate-binding module was identified. Overexpression of this gene in A. oryzae, followed by the purification of the gene product, revealed that the protein exhibits endoglucanase activity with carboxymethyl cellulose as a substrate. Notably, further enzymatic characterization showed that this enzyme could also hydrolyze glucomannan and galactomannan with relatively lower activity than that of endoglucanase, indicating that the enzyme is likely a bifunctional endoglucanase/mannanase. Detailed analyses of the substrate specificity revealed that the enzyme could hydrolyze cello-oligosaccharides larger than cellotetraose, whereas manno-oligosaccharides could not be hydrolyzed unless they were larger than mannopentaose. Therefore, this enzyme has different modes of action toward cello- and manno-oligosaccharides. To the best of our knowledge, this is the first study to purify and characterize a bifunctional endo-β-1,4-glucanase/mannanase from the Aspergillus genus. The ability of the enzyme to degrade both mannan and cellulose could be used for more efficient degradation of lignocellulosic biomass, indicating that the enzyme shows promise for applications in biomass utilization and the food industry. KEY POINTS: • A novel bifunctional endoglucanase/mannanase, EgmA, is identified from Aspergillus oryzae. • EgmA is the second bifunctional endo-β-1,4-glucanase/mannanase of fungal origin. • EgmA has different mechanisms of action toward cello- and manno-oligosaccharides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.